HZNM yields 1000000.00% · PFE yields 6.13%● Live data
📍 HZNM pulled ahead of the other in Year 1
Combined, HZNM + PFE cover 0 of 12 months — good coverage
Which stock is actually better after tax? Adjust your rate to find out.
What's the optimal mix of HZNM + PFE for your $10,000?
Horizon Minerals Corp. engages in the exploration and development of mineral properties in the United States. It primarily focuses on exploring for lithium deposits. The company has interests in the SFE Property, a section of Scotty's Southeast Claims with 312 twenty-acre unpatented mining claims located in Central Nye County, Nevada; the Crystal Basin Claims covering 245 twenty-acre unpatented mining claims situated in Southern Nye County, Nevada; the Cholla Claims with 424 unpatented twenty-acre claims located in eastern San Bernardino County, California; and the North Lobe Claims covering 160 unpatented twenty-acre claims situated in Elko County, northeastern Nevada. It also has interest in 224 claim units totaling 4,480 acres located in Toole County, Utah. The company was formerly known as Safe Dynamics Corp. and changed its name to Horizon Minerals Corp. in March 2013. Horizon Minerals Corp. was founded in 2011 and is headquartered in Las Vegas, Nevada.
Full HZNM Calculator →Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under the Ibrance, Xtandi, Sutent, Inlyta, Retacrit, Lorbrena, and Braftovi brands; and sterile injectable and anti-infective medicines, and oral COVID-19 treatment under the Sulperazon, Medrol, Zavicefta, Zithromax, Vfend, Panzyga, and Paxlovid brands. The company also provides medicines and vaccines in various therapeutic areas, such as pneumococcal disease, meningococcal disease, tick-borne encephalitis, and COVID-19 under the Comirnaty/BNT162b2, Nimenrix, FSME/IMMUN-TicoVac, Trumenba, and the Prevnar family brands; biosimilars for chronic immune and inflammatory diseases under the Xeljanz, Enbrel, Inflectra, Eucrisa/Staquis, and Cibinqo brands; and amyloidosis, hemophilia, and endocrine diseases under the Vyndaqel/Vyndamax, BeneFIX, and Genotropin brands. In addition, the company is involved in the contract manufacturing business. It serves wholesalers, retailers, hospitals, clinics, government agencies, pharmacies, and individual provider offices, as well as disease control and prevention centers. The company has collaboration agreements with Bristol-Myers Squibb Company; Astellas Pharma US, Inc.; Myovant Sciences Ltd.; Akcea Therapeutics, Inc; Merck KGaA; Valneva SE; BioNTech SE; and Arvinas, Inc. Pfizer Inc. was founded in 1849 and is headquartered in New York, New York.
Full PFE Calculator →Save your analysis + weekly dividend insights. Free forever.
⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.